- Therapeutic Cataract & Refractive
- Lens Technology
- Glasses
- Ptosis
- AMD
- COVID-19
- DME
- Ocular Surface Disease
- Optic Relief
- Geographic Atrophy
- Cornea
- Conjunctivitis
- LASIK
- Myopia
- Presbyopia
- Allergy
- Nutrition
- Pediatrics
- Retina
- Cataract
- Contact Lenses
- Lid and Lash
- Dry Eye
- Glaucoma
- Refractive Surgery
- Comanagement
- Blepharitis
- OCT
- Patient Care
- Diabetic Eye Disease
- Technology
Alcon to acquire WaveTec Vision
Alcon has entered into an agreement to acquire WaveTec Vision, developer of the ORA System, the first commercialized intraoperative guidance system for cataract surgeons implanting intraocular lenses (IOLs).
Fort Worth, TX-Alcon has entered into an agreement to acquire WaveTec Vision, developer of the ORA System, the first commercialized intraoperative guidance system for cataract surgeons implanting intraocular lenses (IOLs).
Alcon introduces Air Optix Colors
The ORA System allows surgeons to see incisions and IOL alignment in real time to support optimal positioning of IOLs during cataract surgery. The ORA System performs additional measurements to confirm the surgeon’s lens selection and placement within the eye.
Alcon plans to integrate the ORA System into its existing cataract refractive suite which includes: Verion, the LenSx femtosecond laser, the Centurion phacoemulsification system, and the LuxOR LX3 microscope.
The ORA System obtains intra-operative wavefront data during cataract surgery to calculate IOL power, as well as magnitude and axis of astigmatism. The marriage of the ORA System and Alcon’s Verion imaged-guided system is intended to increase the surgeon’s clinical confidence when using IOLs. According to Alcon, the combined technologies are designed to improve patient outcomes and enhance the overall post-surgical patient experience with IOLs.
Upon closing, Alcon will acquire full rights to the ORA System technology and immediately begin the integration of the company into its surgical business franchise. The transaction is subject to closing conditions, including anti-trust approval.
